Disease spotlight: Duchenne muscular dystrophy (DMD)

Newsletters and Deep Dive digital magazine
Clinical trials face rising complexity, but simplifying processes and focusing on user experiences can enhance efficiency and patient outcomes
Rare disease treatment poses distinct challenges for physicians, patients, caregivers, and pharma companies.
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Phil Johnson chat about why he joined Evidation and his excitement about the company’s mission.
Developments in the oncology space in 2024 brought hope to both industry and patients.
7th Neuroimmunology Drug Development Summit | February 25-27 2025 | Boston, MA
Following a year of exceptional progress in IBD drug development, fierce competition in clinical trials for Chron’s Disease and Ulcerative Colitis remains high, and it’s time for biopharma to push
Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox